NASDAQ · AHCO

AdaptHealth Corp.

$11.06 +$0.30 (+2.79%) 1D Market open

Key Metrics

$1.46B
Market cap
P/E · TTM
$3.29B
Revenue · TTM
−$79.63M
Net income
EPS · TTM $-0.59
Dividend yield
Free cash flow $191.95M
Beta · 1Y 0.40
EBITDA · TTM $364.02M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 20
    A material event was filed (Form 8-K).

    8-K - AdaptHealth Corp. (0001725255) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 17
    From its Apr 28 high, the share price fell 29%.

    Peak close $13.38 on Apr 28; trough close $9.53 on Jun 17. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -29%
  • Mar 24
    The stock moved +10.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 24
  • Feb 24
    The stock moved -13.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 24

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.46B
Enterprise value
Shares outstanding136.1M
52-wk range$8.51 – $13.43
Avg volume · 20D1.2M
Net cash
Book value / share$11.18
IndustryServices-Home Health Care Services
ExchangeNASDAQ
About AdaptHealth Corp.
IPO dateApr 16, 2018
Employees10900

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.45
P/FCF7.63
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -0.9%
Net -2.4%
FCF 5.8%
ROE / ROIC -5.2% · —

Financial Health

Current ratio0.92
Quick ratio0.71
Debt / equity1.21
Debt / EBITDA 5.01
Net cash
Working capital−$55.81M

Cash Flow · TTM

Operating CF $599.97M
Capex −$408.02M
Free cash flow $191.95M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

0.8
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings